Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Hans P Niendorf , P Lengsfeld , M Bräutigam Added: 3 years ago
Contrast-induced nephropathy (CIN) in the actual essence of the term refers to renal damage induced by a contrast medium. The ultimate clinical manifestation of CIN is renal failure requiring dialysis, and this article will concentrate on CIN as a clinical outcome. However, transient rises in serum creatinine have been frequently used as a surrogate marker that is suggested to predict renal… View more

Prevention & Chronic Conditions

Intervention
Percutaneous Coronary Intervention for Chronic Total Occlusion
Author(s): Giovanni Maria Vescovo , Carlo Zivelonghi , Benjamin Scott , et al Added: 3 years ago
Coronary chronic total occlusion (CTO), defined as complete occlusion of a coronary artery for at least 3 months with thrombolysis in myocardial infarction (TIMI) grade 0 flow, represents one of the most complex situations in the field of interventional cardiology.1 Despite an incidence of CTO in patients with stable coronary artery disease (CAD) undergoing coronary angiography of 18–46%, the… View more

Intervention
AHA 2019: Colchicine in Percutaneous Coronary Intervention (PCI)
Author(s): Binita Shah Added: 4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI). Questions: 1.What is colchicine and why study it in PCI? 2.What was the study design, patient population and primary and secondary outcomes? 3.What were your outcomes? 4.How do these compare to those in the COLCOT study? 5.How should your study be interpreted in clinical… View more

Intervention
Author(s): Ahmed M Alabbady , Ahmed S Abdul-Al , Kimberly A Skelding Added: 3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the… View more

Intervention
Author(s): Rhian E Davies , J Dawn Abbott Added: 3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes Stable Angina The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or… View more

Intervention
Author(s): Gregory J Dehmer Added: 3 years ago
The use of percutaneous coronary intervention (PCI) for coronary artery revascularization has grown considerably since the first balloon angioplasty in 1977. Improvements in equipment and drug therapies plus the development of coronary artery stents have all contributed to the growth of PCI as an alternative to surgical revascularization. Compared with the early days of balloon angioplasty, when… View more

Vascular Disease and Surgery

Standards & Guidelines
Mechanical Circulatory Support for Complex High-risk PCI
Author(s): Alexander G Truesdell , Rhian E Davies , Moemen Eltelbany , et al Added: 1 year ago

Heart Failure

Intervention
ESC 23: The OCTIVUS Study
Author(s): Duk-Woo Park , Do-Yoon Kang Added: 7 months ago
ESC 2023 — We are joined onsite by Dr Duk-Woo Park and Dr Do-Yoon Kang (Asan Medical Center, Seoul, KR) to discuss the findings from the OCTIVUS study (NCT03394079). The OCTIVUS study (Seung-Jung Park, CardioVascular Research Foundation, Korea) aims to compare the clinical safety and efficacy of optimal coherence tomography (OCT) guided and intravascular ultrasound (IVUS) guided strategies in… View more

Intervention
Antithrombotic Therapy in Complex PCI Patients Under OAC
Author(s): Despoina-Rafailia Benetou , Panayotis K Vlachakis , Charalampos Varlamos , et al Added: 2 years ago

Anticoagulation

Intervention
The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
Author(s): Charles Simonton , Craig Thompson , Jason R Wollmuth , et al Added: 3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary… View more

Intervention